Gene · 23152
CIC: capicua transcriptional repressor
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. CIC: capicua transcriptional repressor. Genes, record 23152. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23152
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q96RK0 | Protein capicua homolog | 2,517 | 7 | Ensembl, GeneID, HGNC |
Source UniProt
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants775
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CIC papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 57 | 2025 |
| P50CA217694 | SPORE in Soft Tissue Sarcoma | 15 | 2025 |
| P50CA097257 | Brain Tumor SPORE Grant | 13 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 12 | 2025 |
| R01NS027699 | Molecular Studies of Spinocerebellar Ataxia Type 1 | 11 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 10 | 2025 |
| P50CA165962 | Targeted Therapies for Glioma | 5 | 2025 |
| P01CA096832 | NORMAL & NEOPLASTIC GROWTH IN THE BRAIN | 4 | 2025 |
| P30CA034196 | Cancer Center Support (CORE) Grant | 4 | 2025 |
| P50CA211015 | UCLA SPORE in Brain Cancer | 4 | 2025 |
1 to 10 of 775Source NIH's project files
See all 775 nih grantsPapers1,814
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dural CIC::DUX4 sarcoma presenting with intracranial hemorrhage at both initial diagnosis and recurrence: a case report and literature review. | Brain Tumor Pathol | 2026 | 42816716 | PubTator, text mining | PubMed |
| Neuromotor Compromise as a Presenting Symptom in Advanced Lower Extremity Soft Tissue Sarcoma: A Case Series. | HCA Healthc J Med | 2026 | 42751661 | PubTator, text mining | PubMed |
| Non-Meningothelial Mesenchymal Tumor of the Central Nervous System: Case Report and Literature Review. | Neuropathology | 2026 | 42745692 | PubTator, text mining | PubMed |
| Cerebrospinal fluid infection caused by Mixta calida in a patient with sarcoma: Case report with whole-genome sequencing. | Indian J Med Microbiol | 2026 | 42731728 | PubTator, text mining | PubMed |
| Undifferentiated round cell sarcoma with CIC::NUTM1 fusion: expanding the clinicopathologic spectrum of a rare molecular variant of CIC-rearranged sarcoma. | Virchows Arch | 2026 | 42693277 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Refines Diagnosis and Expands Precision Medicine Opportunities in Soft Tissue Sarcomas. | Int J Mol Sci | 2026 | 42653206 | PubTator, text mining | PubMed |
| C1q CIC in Lupus Nephritis: An Analysis of 883 Patients. | Int J Med Sci | 2026 | 42524383 | PubTator, text mining | PubMed |
| AER-DCWGAN: Adversarial Encoder-Regularized Dual-Conditional Wasserstein GAN for Imbalanced Network Intrusion Detection. | Sensors (Basel) | 2026 | 42515390 | PubTator, text mining | PubMed |
| In silico evaluation of the role of PEA3 subfamily ETS transcription factors in chemoresistance in ovarian cancer. | Turk J Med Sci | 2026 | 42499433 | PubTator, text mining | PubMed |
| Isoform-paralog specificity and tissue-dependent vulnerabilities in neurological disorders. | Genes Dev | 2026 | 42481419 | PubTator, text mining | PubMed |
1 to 10 of 1,814
See all 1,814 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23152
GET https://conductscience.org/api/genes/v1/23152/grants?page=2